New nurse-led protocols for stroke patients, based on ACU research, led by the Nursing Research Institute, have resulted in changes to policy, guidelines and clinical practice in Europe and Australia. The protocols were developed through the Quality in Acute Stroke Care (QASC) Trial (published in the Lancet, 2011) to manage fever, hyperglycaemia and swallowing (FeSS) post-stroke.
Professor Sandy Middleton FACN, FAAN is a Professor of Nursing and Director of the Nursing Research Institute at St Vincent’s Health Network Sydney, St Vincent’s Hospital Melbourne and Australian Catholic University. She focusses on stroke and the way research can improve care, particularly analysing the way nurses can initiate care to improve patient recovery.
Professor Middleton was the lead investigator on the landmark NHMRC-funded QASC cluster trial that demonstrated decreased death and dependency following implementation of nurse-initiated protocols to manage fever, hyperglycaemia and swallowing post-stroke, winning multiple national and international awards including ACU’s Vice-Chancellor’s Staff Excellence Award, Excellence in Research and Research Partnerships in 2019. These protocols have been translated into 64 hospitals in 17 European countries and in adopted in 36 NSW hospitals. She has published in high impact journals including The Lancet and The New England Journal of Medicine.
Australian Health Journal spoke with Professor Sandy Middleton on these significant achievements in nurse-led acute stroke care.
-
Addressing Wound Management
The cost of chronic wounds in Australia is estimated to be $3 Billion per year, impacting 420,000 Australians. Not only is this a national economic concern, but more importantly, is the suffering the person may be going through.
Australian Health Journal met with Hayley Ryan, Board Director and Chair at Wounds Australia and Director at WoundRescue to hear her work in chronic wound management, palliative wounds and pressure injury prevention to comfort those living with a wound.
-
Study: First time stroke survivors have substantial immediate and accelerated long term cognitive decline
New evidence from the Centre for Healthy Brain Ageing (CHeBA) indicates that older adults who experience a stroke for the first time will have substantial immediate and accelerated long term-cognitive decline.
-
Report gives insights to clinical trial activity in Australia
Established in 2024, Bellberry is a Adelaide-based national, not-for-profit organisation that provides streamlined scientific and ethical reviews of human research. It is the 2025 winner of the Championing Health Award in the Telstra Best of Business Awards.
Australian Health Journal spoke with Bellberry Limited CEO, Kylie Sproston on the organisation and the findings in activity documented in the Clinical Trial Activity Report (CTAR) 2024.
